NO20032215D0 - Laktamforbindelse - Google Patents

Laktamforbindelse

Info

Publication number
NO20032215D0
NO20032215D0 NO20032215A NO20032215A NO20032215D0 NO 20032215 D0 NO20032215 D0 NO 20032215D0 NO 20032215 A NO20032215 A NO 20032215A NO 20032215 A NO20032215 A NO 20032215A NO 20032215 D0 NO20032215 D0 NO 20032215D0
Authority
NO
Norway
Prior art keywords
lactam compound
lactam
compound
Prior art date
Application number
NO20032215A
Other languages
English (en)
Other versions
NO325217B1 (no
NO20032215L (no
Inventor
Thomas Mitchell Koenig
James Edmund Audia
David Mitchell
Stacey Leigh Mcdaniel
Lynne Ann Buccilli
Gary Lowell Engel
James Abraham Aikins
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20032215D0 publication Critical patent/NO20032215D0/no
Publication of NO20032215L publication Critical patent/NO20032215L/no
Publication of NO325217B1 publication Critical patent/NO325217B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20032215A 2000-11-17 2003-05-15 Laktamforbindelse, fremgangsmate for dets fremstilling samt farmasoytisk sammensetning inneholdende nevnte forbindelse NO325217B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24965600P 2000-11-17 2000-11-17
PCT/US2001/027795 WO2002040451A2 (en) 2000-11-17 2001-11-02 Lactam compound

Publications (3)

Publication Number Publication Date
NO20032215D0 true NO20032215D0 (no) 2003-05-15
NO20032215L NO20032215L (no) 2003-07-16
NO325217B1 NO325217B1 (no) 2008-02-25

Family

ID=22944436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032215A NO325217B1 (no) 2000-11-17 2003-05-15 Laktamforbindelse, fremgangsmate for dets fremstilling samt farmasoytisk sammensetning inneholdende nevnte forbindelse

Country Status (33)

Country Link
US (1) US20040248878A1 (no)
EP (1) EP1353910B1 (no)
JP (1) JP4116431B2 (no)
KR (1) KR20030045194A (no)
CN (2) CN101624372A (no)
AR (1) AR031356A1 (no)
AT (1) ATE362919T1 (no)
AU (2) AU2002224321B2 (no)
BR (1) BR0115424A (no)
CA (1) CA2425497C (no)
CY (1) CY1106682T1 (no)
CZ (1) CZ20031340A3 (no)
DE (1) DE60128587T2 (no)
DK (1) DK1353910T3 (no)
DZ (1) DZ3454A1 (no)
EA (1) EA006919B1 (no)
EC (1) ECSP034598A (no)
ES (1) ES2286162T3 (no)
HR (1) HRP20030385A2 (no)
HU (1) HUP0301862A3 (no)
IL (1) IL155275A0 (no)
MX (1) MXPA03004250A (no)
MY (1) MY141607A (no)
NO (1) NO325217B1 (no)
PE (1) PE20020798A1 (no)
PL (1) PL211018B1 (no)
PT (1) PT1353910E (no)
SK (1) SK287794B6 (no)
SV (1) SV2003000741A (no)
TW (1) TWI235151B (no)
UA (1) UA77165C2 (no)
WO (1) WO2002040451A2 (no)
ZA (1) ZA200303411B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74849C2 (en) * 2000-11-17 2006-02-15 Lilly Co Eli Lactam
RU2423353C1 (ru) 2002-12-20 2011-07-10 Глэксо Груп Лимитед Новые производные бензазепина
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
JP5039543B2 (ja) 2005-04-08 2012-10-03 第一三共株式会社 ピリジルメチルスルホン誘導体
WO2007088878A1 (ja) 2006-01-31 2007-08-09 Api Corporation ベンゾアゼピノン類の製造方法
TW200920362A (en) 2007-09-11 2009-05-16 Daiichi Sankyo Co Ltd Alkylsulfone derivatives
FR2932800B1 (fr) * 2008-06-20 2015-02-20 Servier Lab Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
KR101871011B1 (ko) 2010-09-22 2018-06-25 아레나 파마슈티칼스, 인크. Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료
KR101899014B1 (ko) 2012-01-06 2018-09-17 삼성전자주식회사 비엘디씨 모터의 제어 장치 및 그 방법
CN102690231B (zh) * 2012-04-11 2014-07-09 南京友杰医药科技有限公司 治疗阿尔茨海默病潜在药物司马西特的合成方法
US20160067306A1 (en) 2013-04-19 2016-03-10 National University Corporation Hokkaido University Treatment agent for cognitive impairment induced by amyloid beta-protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these
UA126268C2 (uk) 2015-01-06 2022-09-14 Арена Фармасьютікалз, Інк. СПОСОБИ ЛІКУВАННЯ СТАНІВ, ПОВ'ЯЗАНИХ З РЕЦЕПТОРОМ S1P<sub>1 </sub>
EA201890096A1 (ru) 2015-06-22 2018-08-31 Арена Фармасьютикалз, Инк. КРИСТАЛЛИЧЕСКАЯ L-АРГИНИНОВАЯ СОЛЬ (R)-2-(7-(4-ЦИКЛОПЕНТИЛ-3-(ТРИФТОРМЕТИЛ)БЕНЗИЛОКСИ)-1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ (СОЕДИНЕНИЯ 1) ДЛЯ ПРИМЕНЕНИЯ ПРИ РАССТРОЙСТВАХ, СВЯЗАННЫХ С S1P-РЕЦЕПТОРОМ
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
US20230118517A1 (en) 2020-03-26 2023-04-20 Seagen Inc. Methods of treating multiple myeloma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3812952B2 (ja) * 1996-12-23 2006-08-23 エラン ファーマシューティカルズ,インコーポレイテッド シクロアルキル、ラクタム、ラクトンおよびその関連化合物およびその医薬組成物、並びに該化合物を用いたβ−アミロイドペプチドの放出および/またはその合成を阻害する方法
JP2002518481A (ja) * 1998-06-22 2002-06-25 エラン ファーマシューティカルズ,インコーポレイテッド β−アミロイドペプチドの放出および/またはその合成を阻害するための化合物
CA2390376A1 (en) * 1999-11-09 2001-05-17 William Leonard Scott .beta.-aminoacid compounds useful for inhibiting .beta.-amyloid peptide release and/or its synthesis

Also Published As

Publication number Publication date
SV2003000741A (es) 2003-01-13
MXPA03004250A (es) 2003-09-22
ATE362919T1 (de) 2007-06-15
MY141607A (en) 2010-05-31
EA200300579A1 (ru) 2003-12-25
ZA200303411B (en) 2004-08-02
DE60128587D1 (de) 2007-07-05
ES2286162T3 (es) 2007-12-01
PT1353910E (pt) 2007-08-20
BR0115424A (pt) 2003-10-21
PL360991A1 (en) 2004-09-20
AR031356A1 (es) 2003-09-17
AU2002224321B2 (en) 2006-10-19
CN101624372A (zh) 2010-01-13
IL155275A0 (en) 2003-11-23
EP1353910A2 (en) 2003-10-22
HUP0301862A2 (hu) 2003-09-29
US20040248878A1 (en) 2004-12-09
CN100516047C (zh) 2009-07-22
JP2004521084A (ja) 2004-07-15
DZ3454A1 (fr) 2002-05-23
JP4116431B2 (ja) 2008-07-09
CA2425497C (en) 2010-08-17
EA006919B1 (ru) 2006-04-28
WO2002040451A3 (en) 2003-08-28
CZ20031340A3 (cs) 2004-06-16
CA2425497A1 (en) 2002-05-23
CY1106682T1 (el) 2012-05-23
EP1353910B1 (en) 2007-05-23
HUP0301862A3 (en) 2007-09-28
CN1575282A (zh) 2005-02-02
DE60128587T2 (de) 2008-01-31
WO2002040451A2 (en) 2002-05-23
PE20020798A1 (es) 2002-09-06
TWI235151B (en) 2005-07-01
SK5432003A3 (en) 2004-09-08
PL211018B1 (pl) 2012-03-30
NO325217B1 (no) 2008-02-25
ECSP034598A (es) 2003-06-25
HRP20030385A2 (en) 2003-08-31
SK287794B6 (sk) 2011-10-04
KR20030045194A (ko) 2003-06-09
DK1353910T3 (da) 2007-09-10
NO20032215L (no) 2003-07-16
AU2432102A (en) 2002-05-27
UA77165C2 (en) 2006-11-15

Similar Documents

Publication Publication Date Title
NO20032236D0 (no) Laktamforbindelse
NO20026196L (no) Kinazolinditosylatsalt-forbindelser
DK1619192T3 (da) Arylkondeserede azapolycykliske forbindelser
DK1226127T3 (da) Substituerede phenylsulfamoylcarboxamider
DK1255740T3 (da) Substituerede arylpyraziner
AR028393A1 (es) Iminoazidas substituidas
NO20032215L (no) Laktamforbindelse
PT1268453E (pt) Metabolitos de agonista/antagonista de estrogenio
DE50112662D1 (de) Substituierte benzoylcyclohexenone
AR028302A1 (es) Feniluracilos substituidos
ID29755A (id) Senyawa-senyawa organosilikon
IT250181Y1 (it) Custodia perfezionata per rivoltella
ATE372338T1 (de) Deshalogenverbindungen
NO20030303D0 (no) Kalsilytiske forbindelser
NO20023508L (no) Kalsilyttiske forbindelser
NO20031837D0 (no) Kalsilytiske forbindelser
TR200100070A3 (tr) Bilesim
MX231963B (es) Poliamidas
SE0003477D0 (sv) Compounds
SE0004680D0 (sv) New compound
SE0002234D0 (sv) Novel compounds
SE0003437D0 (sv) Novel compounds
SE0003979D0 (sv) Novel Compounds
SE0003436D0 (sv) Novel compounds
SE0003203D0 (sv) Novel compounds